Loading...

Eyup Keles

Title(s)Associate Professor, Dean's Office
SchoolSchool of Medicine
AddressLocation Required
Varies CA 00000
Phone--
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Eyup Keles, M.D. is board certified in Pediatrics and Pediatric Critical Medicine by the American Board of Pediatrics.

    He received his medical school training at the Istanbul University in Cerrahpasa Turkey in 1999 and completed his Pediatric residency in 2005 at the Bakirkoy Maternity and Children’s Hospital in Istanbul, Turkey. Upon moving to the United States, Dr. Keles was a Clinical Research Fellow in Pediatric Critical Care at Massachusetts General Hospital, Harvard Medical School from 2008 through 2011. From 2009 to 2011 he was a clinical fellow in the Cardiac ICU at Children’s Hospital Boston, Harvard Medical School. He was also a clinical fellow in the Pediatric ICU/ACU at Shriner’s Burn Institute from 2009 to 2011. He then went on to complete a residency in Pediatrics at the University of Arizona. Dr. Keles did transnational research on traumatic brain injury during his fellowship and after completing his Pediatric residency from 2013-2014 in MGH Research Institute Neuroscience Center.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Hemophagocytic lymphohistiocytosis in a patient with hyper IgE syndrome. Pediatr Blood Cancer. 2019 10; 66(10):e27894. White S, Mowrer MC, Jesudas R, Keles ES, Roberts JC. PMID: 31259457.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. The pharmacokinetics and pharmacodynamics of Kollidon VA64 dissociate its protective effects from membrane resealing after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2014 Aug; 34(8):1347-53. Miller BF, Keles E, Tien L, Zhang J, Kaplan D, Lo EH, Whalen MJ. PMID: 24824916.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    3. Kollidon VA64, a membrane-resealing agent, reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab. 2012 Mar; 32(3):515-24. Mbye LH, Keles E, Tao L, Zhang J, Chung J, Larvie M, Koppula R, Lo EH, Whalen MJ. PMID: 22086196.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    Eyup's Networks
    Concepts (25)
    Derived automatically from this person's publications.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _